TIL

NASDAQStock

Instil Bio, Inc.

$8.70-0.33 (-3.65%)

52-Week Range

$6.66

$37.56

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.05

Volume

18.0K

Avg Volume

32.2K

Performance

+13.78%

-19.28%

-66.06%

YTD

-22.36%

-51.63%

-33.72%

-98.35%

Price Chart

ETF Exposure

TIL is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.59%	93,230	$963K	$12.7M	0.79%
IWC	iShares Micro-Cap ETF	0.01%	9,487	$85K	$1.27B	0.60%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	7,492	$67K	$2.37B	0.25%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	1,385	$12K	$41.36B	0.17%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	462	$4K	$10.55B	0.12%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	1,000	$9K	$1.91B	0.15%
VTI	Vanguard Total Stock Market ETF	0.00%	118,992	$840K	$2.10T	0.03%
VXF	Vanguard Extended Market ETF	0.00%	41,737	$295K	$84.10B	0.05%

About TIL ETF Exposure

Instil Bio, Inc. (TIL) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $8.70. Investors can gain exposure to TIL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TIL, sorted by portfolio weight.